Functional characterization of the Drosophila MRP (mitochondrial RNA processing) RNA gene by Schneider, M. D. et al.
Functional characterization of the Drosophila MRP
(mitochondrial RNA processing) RNA gene
MARY D. SCHNEIDER,1,5 ANUPINDER K. BAINS,1 T.K. RAJENDRA,2,3 ZBIGNIEW DOMINSKI,4
A. GREGORY MATERA,2,3 and ANDREW J. SIMMONDS1
1Department of Cell Biology, University of Alberta, Edmonton, Alberta T6G2H7, Canada
2Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
3Department of Genetics, University of North Carolina, Chapel Hill, North Carolina 27599, USA
4Department of Biochemistry & Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, USA
ABSTRACT
MRP RNA is a noncoding RNA component of RNase mitochondrial RNA processing (MRP), a multi-protein eukaryotic
endoribonuclease reported to function in multiple cellular processes, including ribosomal RNA processing, mitochondrial DNA
replication, and cell cycle regulation. A recent study predicted a potential Drosophila ortholog of MRP RNA (CR33682) by
computer-based genome analysis. We have confirmed the expression of this gene and characterized the phenotype associated
with this locus. Flies with mutations that specifically affect MRP RNA show defects in growth and development that begin in the
early larval period and end in larval death during the second instar stage. We present several lines of evidence demonstrating
a role for Drosophila MRP RNA in rRNA processing. The nuclear fraction of Drosophila MRP RNA localizes to the nucleolus.
Further, a mutant strain shows defects in rRNA processing that include a defect in 5.8S rRNA processing, typical of MRP RNA
mutants in other species, as well as defects in early stages of rRNA processing.
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INTRODUCTION
MRP RNA was initially identified as a component of RNase
mitochondrial RNA processing (MRP), an essential, highly
conserved eukaryotic ribonucleoprotein complex that also
contains approximately 10 proteins (Yuan et al. 1991; Schmitt
and Clayton 1992; Chamberlain et al. 1998; Welting et al.
2004; Salinas et al. 2005). Studies in Saccharomyces cerevisiae
and mammals have identified several RNase MRP substrates,
associated with diverse cellular processes that are cleaved in
a site-specific manner. In mammalian cells, RNase MRP was
implicated in processing mitochondrial transcripts comple-
mentary to the origin of replication of the mitochondrial
chromosome, to produce primers for mitochondrial DNA
replication (Chang and Clayton 1987). In S. cerevisiae, it was
known for some time to cleave the rRNA precursor at
a single site, leading to the formation of the 59 end of 5.8S
rRNA (Schmitt and Clayton 1993; Lygerou et al. 1996).
However, the results of a recent study show that inactivation
of MRP RNA results in additional rRNA processing defects
that occur in early stages of the pathway (Lindahl et al. 2009).
Cleavage of B-type cyclin (CLB2) mRNA mediated by
RNase MRP to regulate cell cycle progression was also
observed in S. cerevisiae (Gill et al. 2004). In human cells, a
defect in rRNA processing and regulation of cyclin B mRNA
were also observed; however, direct cleavage of these sub-
strates by RNase MRP has not yet been demonstrated
(Hermanns et al. 2005; Thiel et al. 2005, 2007). Recently, hu-
man MRP RNA (RMRP) was identified as a component of
a novel complex with telomerase reverse transcriptase (TERT)
that functions as an RNA-dependent RNA polymerase. In
this complex, RMRP acts as a template for the synthesis of
dsRMRP RNA, primed by a 39 fold-back structure. dsRMRP
RNA associates with Ago2 and is processed into 22-nucle-
otide (nt) dsRNAs in a Dicer-dependent fashion. It has been
proposed that these dsRNAs represent a novel class of
endogenous siRNAs that regulate RMRP levels by a neg-
ative feedback mechanism (Maida et al. 2009).
MRP RNA was the first noncoding RNA to be associated
with a human disease. Ridanpää et al. (2001) described a set of
mutations in the RMRP gene that cosegregate with the
phenotype of the autosomal recessive disease cartilage-hair
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hypoplasia (CHH). Various RMRP mu-
tations are now known to be associated
with other disorders such as Omenn
syndrome and anauxetic dysplasia (Thiel
et al. 2005; Martin and Li 2007). Short
stature is common to all of these diseases;
however, each disease presents a charac-
teristic spectrum of other defects affecting
a broad range of organs (Makitie et al.
2001a,b; Martin and Li 2007; Toiviainen-
Salo et al. 2008). Recent studies have
identified correlations between specific
molecular defects and disease symptoms
in patients with various RMRP muta-
tions. Mutations that affect rRNA pro-
cessing are correlated with the charac-
teristic anauxetic dysplasia symptom of
severe skeletal defects. Mutations that
result in increased cyclin B mRNA levels
are correlated with symptoms character-
istic of CHH. These patients show less
severe skeletal defects but have higher
incidences of immunodeficiency, hema-
tological abnormalities, and cancer (Thiel
et al. 2005, 2007).
We report the expression of the Dro-
sophila ortholog of MRP RNA (CR33682),
previously predicted by a bioinformatics
screen for MRP RNA sequences (Fig 1A;
Piccinelli et al. 2005). Characterization
of a mutant strain shows that Drosophila
MRP (dMRP) is an essential gene. dMRP
mutants display a severe impairment in
growth, a characteristic shared with hu-
man diseases carrying mutations in this
gene (Martin and Li 2007). These pheno-
typic defects could be the result of impair-
ments at different stages of rRNA process-
ing that we have observed. These include
the classic defect in processing 5.8S rRNA
that has been associated with human and
S. cerevisiae RNase MRP mutants (Schmitt
and Clayton 1993; Lygerou et al. 1996;
Hermanns et al. 2005; Thiel et al. 2005), as
well as a defect in early rRNA processing
similar to a defect recently reported in
S. cerevisiae (Lindahl et al. 2009).
RESULTS
dMRP RNA is expressed throughout the Drosophila
life cycle and localizes to the nucleolus
Expression of dMRP RNA was detected throughout the
Drosophila life cycle (Fig. 2A,B). This is consistent with its
role as a component of RNase MRP in the essential cellu-
lar processes of ribosome biogenesis, mitochondrial DNA
replication, and cell cycle regulation. The major fraction of
RNase MRP in S. cerevisiae (Schmitt and Clayton 1993) and
MRP RNA in mammalian cells is in the nucleolus, specif-
ically in the dense fibrillar component marked by fibrillarin
(Li et al. 1994; Jacobson et al. 1995). In syncytial Drosophila
embryos, dMRP RNA colocalizes with Drosophila fibril-
larin in the nucleolus (Fig. 2C). Similar results were
FIGURE 1. The Drosophila (dMRP) RNA gene. (A) Piccinelli et al. (2005) predicted a potential
dMRP RNA encoded by a gene located in the third intron of CG10365, transcribed from the
opposite strand. (Gray) Translated sequences. (B) Expanded view of the dMRP gene. P{EPgy2}
CG10365EY08633 disrupts dMRP in the dMRPEY08633 mutant strain. Positions of primers used to
amplify the genomic region used to make the pTW -MRP strain (MRP 59A and MRP 59D) are
indicated. (C) Structure of pTW MRP used to make the pTW -MRP strain. Regions inserted into
chromosome 2 by untargeted integration via 59 and 39 P-element sequences are shown. dMRP
genomic sequences were inserted in the opposite orientation relative to the UAS/Hsp70
transcriptional regulatory sequences so that dMRP RNA was expressed from its own regulatory
sequences. The white (+) mini-gene encodes a red eye-color gene for selecting transgenic
individuals. (D) dMRP sequence with potential Pol III regulatory elements. The sequence of the
entire intron containing dMRP is shown. Transcribed sequences are underlined. Positions of PSE
(44 nt) and TATA-like element (23 nt) upstream of the transcription start site (+1) are
indicated above the sequence. (Green nucleotides in promoter elements) Identical nucleotides in
all reference sequences (Hernandez et al. 2007), (blue nucleotides) the same as at least one of the
reference sequences, (red nucleotides) consensus Pol III terminator (Hernandez et al. 2007).
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observed in S2 cells (data not shown). Nucleolar localiza-
tion of dMRP RNA suggests that this is a conserved feature
of MRP RNA.
Characterization of a dMRP mutant strain
Rescue of a dMRP mutant strain with genomic DNA
containing an intact dMRP gene
dMRP is encoded within an intron of the uncharacterized
gene CG10365, but is transcribed in the opposite direction.
We determined that a P-element, P{EPgy2}CG10365EY08633,
inserted in transcribed dMRP sequences results in a lethal
phenotype (Fig. 1A). Due to the large size of the P-element
(10.9 kb), it is unlikely that a product expressed from the
dMRP RNA polymerase III (Pol III) promoter could form
a product with dMRP RNA function. This product would
likely be degraded, resulting in a functional null mutation.
We note that this P-element is inserted in an intron of the
surrounding CG10365 gene, and as such does not disrupt its
translated sequences. Thus, it is possible that the lethal
phenotype was caused by disruption of the dMRP gene,
leaving CG10365 function largely intact. To test this idea, a
P-element vector (pTWMRP) containing a genomic fragment
that encompassed the entire intronic region of the dMRP
gene was inserted into chromosome II and used to rescue the
lethal P-element insertion. The pTWMRP transgene was then
tested in P{Epgy2} CG10365EY08633 mutants (Table 1). In-
dividuals homozygous for the dMRP mutation P{Epgy2}
CG10365EY08633 and the pTWMRP transgene were present in
numbers consistent with random segregation of both in-
sertions, suggesting a full rescue of the lethal phenotype in
these individuals. The viability of dMRP mutant individuals
carrying pTWMRP indicates that the mutant phenotype
resulting from the insertion of P{Epgy2} CG10365EY08633 is
caused by an impairment of the dMRP gene and not
CG10365. CG10365 may therefore be a nonessential gene,
or the P{Epgy2} CG10365EY08633 insertion may not impair its
function to a physiologically significant degree. As the
phenotypes associated with P{Epgy2} CG10365EY08633 appear
to be specific to impairment of dMRP function, we will
hereafter refer to this mutation as dMRPEY08633.
dMRPEY08633 mutants are impaired in growth
and development and die as second instar larvae
A significant defect in growth of homozygous dMRPEY08633
mutants compared with the reference w1118 strain was
observed beginning at 3 d after egg deposition (AED) (Fig.
3A). At 5 d AED the mean cross-sectional area of homozy-
gous dMRPEY08633 mutants was approximately one-third that
of the w1118 strain. Homozygous dMRPEY08633 mutants were
also delayed in development, undergoing the first molt z1
d later than normal. Despite the defects in growth and
delayed development, homozygous dMRPEY08633 mutants
showed no gross physical deformities. Growth and develop-
ment of heterozygous dMRPEY08633 larvae were indistin-
guishable from the normal w1118 strain (Fig. 3A,B).
Homozygous dMRPEY08633 mutants showed a bimodal
pattern of mortality, with z70% of individuals dying
between 5 and 6 days of age while the remaining individuals
FIGURE 2. Expression and nucleolar localization of dMRP RNA. (A)
dMRP RNA is expressed throughout Drosophila development. North-
ern blot of total Drosophila RNA probed with dMRP antisense RNA.
dMRP RNA (arrow) is predicted to be 383 nt long, including the
termination signal. (B) rRNA (arrow) as a loading control is
visualized by ethidium bromide staining. (C) dMRP RNA colocalizes
with fibrillarin in syncytial Drosophila embryos. dMRP RNA was
detected by FISH, fibrillarin with rabbit anti-Drosophila fibrillarin
antibody. (D) Control FISH without RNA probe. DNA stained with
PicoGreen was used as a counterstain instead of fibrillarin to show
a lack of nuclear localization of low signal levels in the red channel.
Fibrillarin distribution varies considerably with cell cycle and does not
consistently mark each nucleus. (C,D) Images of a single confocal
plane. Scale bar, 200 mm.
TABLE 1. Rescue of the dMRPEY08633mutant strain


















Individuals homozygous for P{EPgy2} CG10365EY08633 were ob-
served, indicating rescue of the lethal phenotype. Individuals
homozygous for both P{EPgy2} CG10365EY08633 and pTW -MRP
appear in numbers consistent with random segregation of both
insertions. Genotypes were analyzed approximately seven gener-
ations after establishing the strain.
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lingered as second instar larvae for up to 17 d AED (Fig.
4A), which is several days after normal individuals have
reached adulthood. Mouth hooks examined after death had
two to four teeth, characteristic of the second instar stage
(Fig. 4B; Apatov 1929). Northern blot analysis of dMRP
RNA expression levels showed a progressive decline in
homozygous dMRPEY08633 mutants from 1 to 5 d of age
while levels remained constant in dMRPEY08633/GFP hetero-
zygotes (Fig. 5). This progressive decline in dMRP RNA
levels is likely due to gradual depletion of maternal dMRP
RNA and correlates with the timing of impairments in
growth and development prior to mortality.
dMRPEY08633 mutants show impaired rRNA processing
To identify a potential physiological defect affecting growth
and/or development of dMRPEY08633 mutants, we examined
the well-documented role for MRP RNA as a component of
RNase MRP in the endonucleolytic cleavage of the rRNA
precursor leading to formation of the 59 end of 5.8S rRNA.
Mutations in S. cerevisiae and human MRP RNAs result in
accumulation of unprocessed or long forms of 5.8S RNA
(5.8SL) relative to the processed short form (5.8SS) (Schmitt
and Clayton 1993; Lygerou et al. 1996; Hermanns et al. 2005;
Thiel et al. 2005). Our analysis of the relative abundance of
these two forms of 5.8S rRNA in dMRPEY08633 mutant larvae
showed an increase in the abundance of the 5.8SL form (Fig.
6). This result is consistent with a defect in a subset of
previously described RNase MRP mutants that has been
described in other species (Schmitt and Clayton 1993;
Lygerou et al. 1996; Hermanns et al. 2005; Thiel et al.
2005, 2007).
A recent study identified an additional role for S.
cerevisiae RNase MRP in early stages of rRNA processing.
In this study, a reduction in levels of normal early in-
termediates was observed in MRP RNA mutants, which was
accompanied by the appearance of abnormal intermediates
(Lindahl et al. 2009). To investigate a potential role for
dMRP in regulating early processing steps, we examined
rRNA intermediates in homozygous dMRPEY08633 mutants.
Figure 7 is a schematic representation of two pathways for
processing the primary pre-rRNA transcript in Drosophila
melanogaster. The canonical pathway is analogous to that
described in vertebrates (Levis and Penman 1978). An
alternative pathway was subsequently proposed by Long
and Dawid (1980) that differs from the canonical pathway in
the order of early cleavages steps.
Northern blots of total RNA from homozygous
dMRPEY08633 mutants, dMRPEY08633/GFP heterozygotes of
the same age, and w1118 second instar larvae were hybrid-
ized with oligonucleotide probes (oligos) complementary
to several regions of the primary pre-rRNA transcript (Fig.
8B; Table 2). RNA levels for each genotype were normalized
for similar levels of mature rRNA to compare processed
with unprocessed rRNA levels. Probing with an oligo
complementary to the external transcribed spacer (ETS)
revealed a 4.2-kb RNA species in homozygous dMRPEY08633
FIGURE 3. Homozygous dMRPEY08633 mutant larvae are delayed in
growth and development. (A) dMRPEY08633/dMRPEY08633 mutants
showed a significant growth delay (mean cross sectional area for 20
individuals) beginning before 72 h AED compared with control
(w1118) or heterozygous dMRPEY08633/GFP siblings. (B) Comparison of
5-d-old dMRPEY08633/dMRPEY08633 and dMREY08633/GFP mutant indi-
viduals. Scale bar, 1 mm. (C) The first molt in dMRPEY08633/dMREY08633
mutants occurred z1 d later than control (w1118) or heterozygous
dMRPEY08633/GFP siblings raised in the same vial(s). (dMRP)
dMRPEY08633.
FIGURE 4. Homozygous dMRPEY08633 mutants die during the second
larval instar. (A) A bimodal pattern of mortality was observed, with
z70% of individuals dying 5–6 d AED. The remaining individuals
lingered as second instar larvae for up to 17 d compared with control
populations, which reached adulthood at z10 d AED. (B) Represen-
tative mouth hook from a homozygous dMRPEY08633 larva examined
post mortem. All mouth hooks had two to four teeth, indicative of the
second instar stage. (Below) Approximate development timeline for
wild-type individuals. (dMRP) dMRPEY08633.
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mutants that was not detected in phenotypically normal
larvae. A 4.2-kb molecule (designated intermediate a) was
also seen when blots were probed with oligos complemen-
tary to the internal transcribed spacer (ITS)1, ITS2, and
5.8S regions (Fig. 8A). This molecule spans from the 59 end
of the primary transcript to the ITS2 region. Assuming that
it is a product of a cleavage at one of the normal sites, it
would be the product of an initial cleavage at site 5 (Fig. 7).
A 3.0-kb molecule (designated intermediate b) was
detected only in RNA from homozygous dMRPEY08633
mutants on blots probed with ITS1, ITS2, and 5.8S oligos
but not the ETS oligo (Fig. 8A). This could represent the
product of intermediate a, following cleavage at site 1,
which removes the ETS from the primary transcript. The
experimentally determined sizes of both of these molecules
are consistent with their expected sizes, which were de-
termined by comparison with sizes of previously charac-
terized precursors (Long and Dawid 1980) or calculated
from the sequence of the primary RNA polymerase I pre-
rRNA transcript based on the annotation by Tautz et al.
(1988) (see Table 3). Neither of these molecules corre-
sponds to products of either of the previously described
Drosophila rRNA processing pathways (Fig. 7).
Accumulation of a 0.58-kb molecule (designated interme-
diate e) was detected in RNA from homozygous
dMRPEY08633 mutants with ITS2 and 5.8S oligos but not
with ETS or ITS1 oligos (Fig. 8). The size (Table 3) and
structure of this molecule suggest that it may correspond to
a previously observed normal precursor of 5.8S and 2S
rRNAs, designated intermediate e by Long and Dawid
(1980). However, the boundaries of both of these interme-
diates need to be defined more accurately to determine their
relationship. Intermediate e, identified in Figure 8, could be
the product of further processing of intermediate b or result
from abnormal accumulation of an intermediate produced
by a normal processing pathway. We were unable to detect
this intermediate in RNA from phenotypically normal
larvae. If intermediate is a processed product of intermediate
b, then the three intermediates a, b, and that accumulates in
homozygous dMRPEY08633 mutants may represent a series of
intermediates in an atypical processing pathway generated by
cleavages at normal sites used in an atypical order (Fig. 8B).
Our probes detected several RNAs that were present in
RNA from homozygous dMRPEY08633 mutants as well as the
two phenotypically normal genotypes, whose identities we
could not determine. 5.8S and ITS1 oligos both hybridized
to a 2.0-kb fragment that is close in size to the 28Sb mature
rRNA and could result from nonspecific hybridization to
this abundant RNA species. The 0.35-kb fragment seen
with the ITS2 and 5.8S probes and the 0.10-kb fragment
seen with the ITS1 probe do not correspond to known
products of Drosophila rRNA processing pathways. They
may represent novel processing intermediates or may be
detected as a result of nonspecific hybridization with un-
related small RNAs.
DISCUSSION
Drosophila MRP RNA is orthologous to MRP RNA
genes in other species
Our results support the idea that dMRP RNA shares
structural and functional homology with conserved MRP
RNA genes previously characterized in other eukaryotes. In
addition to the structural and sequence similarities between
dMRP RNA and MRP RNAs in other species described by
Piccinelli et al. (2005), we identified genomic sequences
flanking dMRP RNA resembling RNA Pol III regulatory
elements (Fig. 1; Hernandez et al. 2007). The presence of
these elements suggests that in Drosophila, as in most species,
FIGURE 6. 5.8S rRNA processing is impaired in dMRP mutants. Total
RNA isolated from wild-type (WT) and dMRPEY08633 mutant larvae
was separated in a denaturing polyacrylamide gel and either directly
analyzed by staining with ethidium bromide (A) or used for Northern
blotting with probes specific to the dMRP RNA or 5.8 rRNA (B). The
two forms of 5.8S rRNA are indicated. (dMRP) dMRPEY08633, (WT)
Oregon R strain.
FIGURE 5. dMRP RNA levels decline at the time of growth arrest and
death in dMRPEY08633 mutants. A Northern blot of total RNA from
homozygous dMRPEY08633/dMRPEY08633 mutants and their hetero-
zygous dMRPEY08633/GPF siblings during larval development shows
levels of dMRP RNA (MRP). The same blot was probed for RpL32
mRNA (RpL32) as a loading control. (dMRP) dMRPEY08633.
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MRP RNA is transcribed by RNA Pol III (Dieci et al. 2007).
Our success in rescuing the dMRPEY08633 mutant strain with
a genomic fragment containing these sequences is consistent
with the idea that these are functional dMRP transcriptional
regulatory sequences.
A number of additional observations support the idea that
this gene is orthologous to the gene encoding MRP RNA in
other eukaryotes. Essentially uniform expression of dMRP
RNA throughout the Drosophila life cycle (Fig. 2A) is con-
sistent with its role in fundamental cellular processes such as
ribosome biogenesis, mitochondrial DNA replication, and cell
cycle regulation (Chang and Clayton 1987; Schmitt and
Clayton 1993; Lygerou et al. 1996; Gill et al. 2004; Thiel
et al. 2007). Further, dMRP RNA localizes to the nucleolus,
the same compartment to which the bulk of S. cerevisiae
RNase MRP (Gill et al. 2006) and mammalian MRP RNA
localize (Fig. 2C; Li et al. 1994; Jacobson et al. 1995).
The rRNA processing pathway has not been characterized
as extensively in Drosophila as in other species. There have
been few additional studies of this pathway since mapping
of cleavage sites by Long and Dawid (1980). In their study,
a single form of 5.8S was identified. We have identified both
long and short forms of 5.8S rRNA in normal larvae (Fig.
6). Our data also reveal similarities in rRNA processing
between dMRP RNA and MRP RNA
orthologs in other species. S. cerevisiae
and human MRP RNA genes have been
known for some time to cleave the
rRNA precursor leading to the forma-
tion of the 59 end of the 5.8SS rRNA. A
reduction in the level of 5.8SS, accom-
panied by an increase in the level of the
unprocessed 5.8SL, in MRP RNA mu-
tants is a strong indication of this
function (Schmitt and Clayton 1993;
Lygerou et al. 1996; Hermanns et al.
2005; Thiel et al. 2005, 2007). Homozy-
gous dMRPEY08633mutants display a sim-
ilar change in relative abundances of the
two forms of 5.8S rRNAs, indicating a
similar function for this gene in Dro-
sophila (Fig. 6).
Drosophila and S. cerevisiae MRP
RNA genes show similar effects
on early rRNA processing
We have observed an additional defect in
early rRNA processing events that re-
sembles one that was recently reported in
S. cerevisiae MRP RNA mutants. In these
mutants, an atypical 24S intermediate,
spanning from the 59 end of the ETS to
the 39 end of 5.8S, was detected. It was
proposed that this intermediate was
generated by a premature cleavage in ITS2 followed by
39 to 59 exonuclease trimming to the 39 end of 5.8S (Lindahl
et al. 2009). The 24S intermediate resembles intermediate
a in homozygous dMRPEY08633 mutants (Fig. 8). Interme-
diate a, like the 24S intermediate, begins with the ETS at the
59 end. ITS2 sequences at the 39 end suggest that it was
generated by premature cleavage at the normal cleavage site
5 (Fig. 7). However, unlike the 24S intermediate, interme-
diate a retains ITS2-derived sequences (Fig. 8). Accumu-
lation of intermediate b and intermediate e in addition to
intermediate a suggests further processing of intermediate
a. Together, these fragments could represent a series of
intermediates in an atypical processing pathway (Fig. 8).
Normally, the pre-rRNA transcript is cleaved at defined
sites in a consistent order to produce a defined set of rRNA
intermediates that are ultimately processed into mature
rRNAs. To account for the atypical pathway in homozygous
dMRPEY08633 mutants, we propose a role for RNAse MRP in
maintaining the order of early cleavage steps. Specifically,
RNase MRP could contribute to suppressing premature
cleavage at site 5 in ITS2 (Fig. 7). This function could be
performed as part of a large complex, associating with the
pre-rRNA and masking cleavage site 5. Subsequent confor-
mational changes in this complex could expose site 5 for
FIGURE 7. A D. melanogaster ribosome gene and previously described rRNA processing
pathways. (A) The primary rRNA transcript is drawn approximately to scale. (Solid boxes)
Regions that are processed into mature rRNA. ETS (external transcribed spacer), ITS1
(internal transcribed spacer 1), and ITS2 (internal transcribed spacer 2) (open boxes) are
removed during processing. Endonucleolytic cleavage sites are indicated by numbered marks
(1–6). (B) The canonical and alternative rRNA processing pathways that have been previously
described in D. melanogaster. Processing intermediates designated according to Long and
Dawid (1980) are indicated by letters above each fragment.
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cleavage at the appropriate processing step. At a later stage
in the pathway RNase MRP would perform its previously
documented function of an endoribonuclease, cleaving the
pre-rRNA precursor at a single site in ITS1 to process the
59 end of the 5.8S rRNA.
Similar aberrant intermediates in Drosophila and S.
cerevisiae mutant MRP RNA genes could be formed by a
common mechanism, such as the one described above.
Alternatively, they could form as a result of the mechanism
proposed by Lindahl et al. (2009). In this mechanism
RNase MRP could function as an
endoribonuclease to directly cleave the
pre-rRNA transcript at multiple sites. In
addition to its previously characterized
role of processing the 59 end of the 5.8S
rRNA, it would also cleave early in-
termediates. The absence of this activity
in MRP RNA mutants this would lead
to reduction of normal early rRNA
precursors. The 24S intermediate would
be produced in the absence of this
activity while cleavage in ITS2 con-
tinues.
Elevated levels of atypical intermedi-
ates in the pathway outlined in Figure 8
could accumulate as a result of inef-
ficient processing. Normally, early cleav-
ages of the primary pre-rRNA transcript
separate the 18S region from the 28S
region, followed by further processing
along separate pathways to form distinct
40S and 60S ribosomal subunits (Fatica
and Tollervey 2002). In intermediate a
of the atypical pathway, the 5.8S and 2S
regions are inappropriately linked to the
18S region, which is destined to become
part of the 40S subunit. An inability by
the normal pathway to process interme-
diate a could result in an increase in its
levels. Inefficient processing of interme-
diate a by an atypical pathway could
lead to accumulation of additional in-
termediates such as intermediates b and
e. Eventually, accumulation of atypical
intermediates surpassing critical levels
could interfere with normal rRNA pro-
cessing pathways and lead to defects in
ribosome biogenesis. This model is
consistent with a reduction in levels of
normal early processing intermediates
in S. cerevisiae MRP RNA mutants
reported by Lindahl et al. (2009) and
predicts that analysis of physical and
morphological features of ribosomal
subunits or nucleoli where they are
assembled could reveal additional defects.
Intermediate e resembles a precursor of 5.8S and 2S
rRNAs previously identified by Long and Dawid (1980).
Both molecules span from 5.8S to ITS2; however, their
precise boundaries have not yet been determined. Based on
analogy with the S. cerevisiae rRNA processing pathway
(Fatica and Tollervey 2002), two forms of intermediate e
would be expected in normal individuals, one the product
of processing initiated by RNase MRP cleavage and another
unprocessed form. In Drosophila, intermediate b is the likely
FIGURE 8. rRNA precursors in dMRPEY08633 mutants and a novel processing pathway that they
may represent. (A) Northern blot analysis of rRNA precursors in dMRPEY08633/dMRPEY08633
mutants (5 d AED), their heterozygous dMRPEY08633/GPF siblings (5 d AED), and second
instar wild-type (WT) (w1118) larvae. Loading was normalized to similar levels of mature
rRNA. Blots probed with ETS1 and ITS2 oligos were subsequently probed with a 28Sb oligo to
show similar loading. Similar loading for the blot probed with the 5.8S oligo is indicated by the
mature 5.8S product. The blot probed with ITS2 was stripped and reprobed with ITS1. The
primary transcript (pre) and mature products are indicated. Novel processing intermediates
are identified by letters that correspond to intermediates shown in the pathway below.
Previously characterized intermediates b (seen in RNA from dMRPEY08633/GPF larvae probed
with ETS probe) and d (seen in RNA from dMRPEY08633/GPF and w1118 larvae) probed with
ITS2 probes are identified as in Figure 7. Fragments of unknown identities are indicated by
their apparent molecular weight (kb). 5.8S and ITS1 oligos both hybridized to a 2.0-kb
fragment that is approximately the size of the 28Sb mature rRNA and could result from
nonspecific hybridization to this abundant RNA species. The 0.35-kb and 0.10-kb fragments
seen with the 5.88 and ITS1 probes, respectively, do not correspond to known products of the
Drosophila rRNA processing pathway. They may represent novel intermediates of may result
from nonspecific hybridization with unrelated small RNAs. (B) Map of the primary rRNA
transcript is represented as in Figure 7. (Arrows) Positions of oligonucleotide hybridization
probes. Probes are complementary to the following regions: ETS, ITS2, 5.8S, ITS1, and 28S.
Initial cleavages of the rRNA processing pathway represented by these fragments are shown
below the primary transcript. Further processing is likely to follow the canonical pathway.
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substrate for these alternative cleavages (Fig. 7). At this time
we cannot determine which of the two predicted forms of
this intermediate (or perhaps both) we detect in homozy-
gous dMRPEY08633 mutants since their size difference is
likely to be very small. In S. cerevisiae there is only a 7-nt
difference between the two forms (Shuai and Warner 1991).
However, accumulation of intermediate e in homozygous
dMRPEY08633 mutants with reduced levels of dMRP RNA
suggests that it could be the precursor of the long form of
the 5.8S rRNA that has not been cleaved by RNase MRP.
Determining the precise 59 boundary of this intermediate
would determine if it is indeed the 5.8SL precursor. If
intermediate e in homozygous dMRPEY08633 mutants is
a precursor of 5.8 SL, it is tempting to speculate that the
pathway in Fig. 8B could function in normal individuals as
a result of incomplete suppression of premature cleavage in
ITS2 to produce low levels of 5.8 SL.
Mutation of dMRP phenotypically resembles human
RMRP mutants
The similarity in phenotype of the dMRPEY08633 mutant
strain with human patients with RMRP mutations further
supports the idea of functional homology between these
genes. The impairment in growth of dMRPEY08633 mutant
larvae resembles the short stature thought to be caused by an
intrinsic defect in proliferation of cells in human patients
with RMRP mutations (Pierce and Polmar 1982). It is not
clear which of the three RNase MRP functions may be
causing the defects in growth and development seen in the
dMRPEY08633 mutants. It is unlikely that it is an impairment
of cell cycle regulation by a defect in cyclin B mRNA
degradation because cyclins A, B, and B3 are not expressed
in endoreplicating cells (Lehner and O’Farrell 1989, 1990),
which constitute most of the larval tissues. The dMRPEY08633
mutant phenotype may be most similar to a class of human
RMRP mutations that is associated with impaired rRNA
processing that does not alter cyclin B mRNA degradation.
This class of mutations is associated with a severe growth
defect seen in the disease anauxetic dysplasia.
The potential impact of a defect in mitochondrial func-
tion on dMRPEY08633 mutants cannot be inferred from
studies of human RMRP mutations because defects in
mitochondrial function have not yet been detected in
these patients (Hermanns et al. 2005).
Indeed a potential role for RNase MRP
in mitochondrial DNA replication has
been controversial. The enzyme was
initially isolated from mouse cells and
shown to cleave an RNA representing
the primer for mitochondrial DNA rep-
lication (Chang and Clayton 1987). This
activity was dependent on complemen-
tarity of a segment of MRP RNA to
sequences of the RNA substrate (Bennett
and Clayton 1990). However, the cleavage site on the
substrate is 6–10 nt from the in vivo cleavage site, suggesting
that the in vitro activity may be an artifact (Kiss and
Filipowicz 1992). In favor of a role for RNase MRP in
mitochondria, there is good evidence for localization of
MRP RNA to mitochondria of mouse cardiomyocytes by in
situ hybridization (Li et al. 1994). The recent purification of
a mitochondrial enzyme consisting of MRP RNA with
a protein composition distinct from nucleolar RNase MRP
provides convincing evidence for a mitochondrial function
in S. cerevisiae (Lu et al. 2010).
In Drosophila, mutations in a variety of mitochondrial
functions have been described. These mutations can affect a
number of diverse processes such as apoptosis (Abdelwahid
et al. 2007), spermatogenesis (Hales and Fuller 1997), and
growth in both mitotic and endoreplicating tissues (Morris
et al. 2008). The latter effect is consistent with the
impairment in growth displayed by dMRPEY08633 mutants.
We have been unable to detect localization of dMRP RNA
to mitochondria in several tissues that we examined,
with the exception of occasional localization to mitochon-
dria in third instar larval muscle (data not shown).
Additional analysis employing a variety of experimental
approaches could establish whether dMRP RNA functions
in mitochondria. These could include additional attempts
at localization of dMRP RNA to mitochondria by in situ
hybridization as well as purification of RNase MRP activity
from mitochondria. In Drosophila and other metazoans,
identifying a mitochondrial RNase MRP would be more







aIndicates the complementary position on primary transcript.
TABLE 3. Sizes of rRNA precursors in Figure 8






e ; 0.5b 0.58
aExpected sizes were calculated from the sequence of the primary
RNA polymerase I pre-rRNA transcript annotated by Tautz et al.
(1988) based on positions of cleavage sites identified by Long and
Dawid (1980).
bExpected sizes are based on sizes of precursors previously
characterized Long and Dawid (1980).
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likely in tissues that are known to be actively replicating
mitochondrial DNA.
The defects that we report in growth of dMRPEY08633
mutants are consistent with impaired rRNA processing and/
or impaired mitochondrial functions, based on phenotypic
comparisons of other genetic defects in these processes.
Defects in development may be an indirect consequence of
growth defects. In Drosophila larvae there may be a require-
ment to reach a certain size before proceeding to the next
stage of development.
We have shown that the single Drosophila homolog of
MRP functions analogously to mammalian MRP. The well-
characterized RNAi pathway in Drosophila (Kim et al. 2009)
together with the recent discovery of RMRP-derived endog-
enous siRNAs in human cells (Maida et al. 2009) facilitates
future studies of the relatively unexplored area of RNAi-
mediated regulation of noncoding RNAs. Our identification
of a Drosophila strain with a mutation in MRP RNA will be
a useful tool in these future endeavors.
MATERIALS AND METHODS
Drosophila culture and strains
Drosophila melanogaster strains were maintained at 18°C or 25°C
according to standard maintenance procedures on semisolid
medium consisting of 1.2% brewer’s yeast, 1.2% agar, 8%
cornmeal, 7.5% v/v blackstrap molasses supplemented with 0.25
g of methyl 4-hydroxybenzoate (Sigma, dissolved in 1.5 mL of
95% ethanol) as a preservative. The following stocks, obtained
from the Bloomington Drosophila Stock Center, were used: the
normal w1118 strain; second chromosome balancer CyO/Sco, third
chromosome balancers w-; TM3 Sb1/Ly and w-; Sb1/TM3 P(w+mC =
ActGFP) JMR2,Ser1 and strains bearing the lethal P-element insertion
in CG10365; P[EPgy2] CG10365EY08633.
Generation of transgenic animals
A genomic region that included the dMRP gene was PCR-
amplified from pBAC11E7 (GenBank accession no. AC008201.8)
with MRP59A: CACCCGTTGAGGACAAAGAGGTGAGTA and
MRP39D: GCTGCTTGAGATAATCCAGTGCCG primers that
were derived from flanking CG10365 coding sequences and cloned
into pENTR/D (Invitrogen) to make pENTRMRP. This entry
vector was then recombined into pTW (provided by T. Murphy,
Carnegie Institute, Troy, MI), inserting the dMRP gene into pTW
to make pTWMRP. Note that the dMRP genomic region was
inserted in the opposite orientation to the UAS promoter in this
vector so that dMRP RNA would be expressed from its own
regulatory sequences. Wild-type w1118 flies were transformed with
pTWMRP to make the w-; pTW -MRP strain.
Observations of Drosophila growth and development
Embryos were collected on apple juice-agar plates. After hatching,
larvae were maintained at 25°C on the same plates supplemented
with yeast paste spread for the period of observation. Homozy-
gous dMRPEY08633 mutants were identified as non-GFP individuals
of the strain P{Epgy2} CG10365EY08633/w+; Sb1/TM3 P (w+mC =
ActGFP) JMR2,Ser1 (abbreviated as dMRP/GFP). The lethal stage
of mutant larvae was determined by observation of mouth hooks
mounted under #1.5 coverslips in standard tissue mounting
medium (5 g of Mowiol 40-88, 20 mL of PBS, 10 mL of glycerol,
2.5% DABCO [1,4-diazabicyclo(2.2.2)octane]).
rRNA processing analysis
Total RNA isolated from Oregon-R and dMRPEY08633mutant larvae
(z2.5 mg per lane) was separated in an 8%/7 M urea poly-
acrylamide denaturing gel and either stained with ethidium bromide
for direct RNA visualization or transferred to Hybond-N+ mem-
brane (Amersham Biosciences) for Northern analysis with 32P-
labeled probes specific to the MRP RNA or 5.8S rRNA (see below).
Templates for probe labeling were generated by PCR using the
primers MRP fwd: 59-AAGTCCCCGGGCCTAGGATAGAAAG-39;
MRP rev: 59-CGGTTTCTCAGACGAGAAAGTGTGTG-39; 5.8S
rRNA fwd: 59-AACTCTAGGCGGTGGATCACTCGGC-39; 5.8S
rRNA rev: 59-CAGCATGGACTGCGATATGCGTTCA-39. Note:
5.8S primers were chosen from the sequence annotated as
CR40454 (Flybase). For analysis of early rRNA intermediates,
oligonucleotide probes were 32P end-labeled with [g-32P]ATP
(3000 Ci/mmol, 10 mCi/mL, Perkin Elmer) using T4 polynucle-
otide kinase (Invitrogen) by the forward reaction according to the
manufacturer’s protocol.
RNA extraction and Northern blot analysis
Total RNA was extracted using TRIzol (Invitrogen) from adults
and staged collections throughout development. Equal amounts of
denatured RNA (1–2 mg) were loaded in RNA gel loading buffer
(Eppendorf); 2.5–5 mL of buffer for each 1.0 mL of RNA.
Redistilled formamide (Invitrogen) was added to samples to
a minimum of 60% final concentration to allow fractionation
on a native 2% agarose gel (Masek et al. 2005). RNA was capillary-
transferred to a Brightstar-Plus Membrane (Ambion) and UV
cross-linked with a 120-mJ burst for 30 sec. The membrane was
pre-hybridized in 5–10 mL of hybridization buffer (3 M urea, 53
SSC, 0.1% [w/v] N-laurylsarcosine, 0.02% SDS, 0.5% BSA, 0.1
mg/mL sonicated salmon sperm DNA) in a glass hybridization
tube for 1 h at 60°C.
Hybridization buffer was replaced with 5 mL of fresh buffer
containing the appropriate antisense RNA probe labeled with
[a-32P]UTP, and the membrane was hybridized overnight at 60°C.
A probe encompassing the entire transcribed region of dMRP
(Piccinelli et al. 2005) was used to detect dMRP RNA. This region
was PCR-amplified with MRP forward (GCCGGTTTGAGTCTTCC)
and MRP reverse (TAATACGACTCACTATAGGGAAAAAAAGT
GCGCCG) primers from pBAC11E7. The antisense probe was
transcribed with T7 polymerase from T7 promoter sequences added
to the template in the MRP reverse primer. The membrane was
stripped and hybridized to a probe detect the RpL32 gene as
a loading control. The template for RpL32 (CG7939) was amplified
from the cDNA RH03940 using T3 and T7 primers from the
corresponding promoter sequences in the polylinker of pFLC-1. The
antisense probe was transcribed using T3 polymerase. Probes were
labeled with 32P in a 20-mL transcription reaction containing T7/T3
Buffer (Invitrogen); 0.5 mM each of ATP, CTP, and GTP; 12 mM
UTP; 20 U of SUPERase-In (Ambion); 50 U of T7 polymerase
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(Invitrogen); 100 ng of DNA template; and 50 mCi of [a-32P]UTP
(800 Ci/mmol, 20 mCi/mL, Perkin Elmer).
In situ hybridization
Transcribed dMRP sequences were PCR-amplified from pBAC11E7
with the primers MRP fwd GCCGGTTTGAGTCTTCC and MRP
rev GGAGTGCGCCGTCCGAGTT. Using this product as a tem-
plate, a subregion of the dMRP gene, consisting of nucleotides 126–
366 with T7 promoter sequences appended, was amplified in a
subsequent step using the primers MRP2 59 CACAAAACACCCAC
CCCTGTG and MRP-2 39 + T7 TAATACGACTCACTATAGGG
TCCGAGTTTCCCAATGTAA. A digoxygenin-labeled antisense
RNA probe transcribed from this template was hybridized to fixed
embryos as described in Hughes and Krause (1999). RNA probes
were visualized by fluorescent antibody staining using a primary
sheep anti-DIG antibody (1:200, Roche) and secondary anti-sheep
Alexi-conjugated fluorescent antibody (1:2000, Molecular Probes).
Fibrillarin was detected with rabbit anti-fibrillarin antibody (1:4000,
Abcam).
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